Company News

ScreenPro Announces Grant of Stock Options

ScreenPro Announces Grant of Stock Options

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company has granted stock options ("Options") to employees, officers and directors of the Company.

The Company has issued incentive stock options to purchase up to 4,800,000 shares of the Company as of January 27, 2023, in accordance with the Company's Stock Option Plan. The Options are exercised at $0.05 per common share, expiring January 26, 2025.

About ScreenPro

Founded in 2020, ScreenPro Security is a health and wellness management company that delivers professional health and medical solutions to Canadians. With a focus on concierge medical services, ScreenPro Security offers personalized health care services such as IV vitamin therapy, personal home care, nurse care, on-call urgent medical care, nutrition, and health screening services, such as COVID-19 testing. Our team of board-certified physicians and health care professionals bring years of expertise to provide knowledgeable and trustworthy solutions to improve patients' overall health outcomes.

For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.

For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.

Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Investor Relations & Communications

Priya Monique Atwal, Director of Communications
Tel: (416) 901-5611 x 204
Email: priya@screenprosecurity.com

Andrew Ryu, Chief Executive Officer and Chairman
Tel: 416-901-5611 x 201
Email: aryu@screenprosecurity.com

Forward Looking Statements:

Certain statements contained in this news release may constitute forward‐looking information, including statements relating to the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/152972

News Provided by Newsfile via QuoteMedia

SCRN:CC
The Conversation (0)
Naturevan Expands to Alberta

Naturevan Expands to Alberta

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is proud to announce that its wholly-owned subsidiary, Naturevan Nutrition Ltd. ("Naturevan"), now has its products available at Imagine Health Pharmacies & Research ("Imagine Health") facilities in Calgary and Edmonton. This is in line with Naturevan's strategy to increase and diversify its distribution channels.

The Company is thrilled about this partnership with Imagine Health to bring Naturevan products to their customers. Naturevan is committed to making high-quality, natural health and wellness products accessible to everyone, and this partnership is a significant step in that direction.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Announces Closing of Non-Brokered Private Placement Financing

ScreenPro Announces Closing of Non-Brokered Private Placement Financing

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that further to the news release of November 10, 2022, the Company has closed a non-brokered private placement financing of units of the Company ("Units") at a price of $0.05 per Unit (the "Private Placement"). The Company has issued an aggregate of 9,700,000 units and a further 8,600,000 common shares at $0.05 per share pursuant to the Private Placement with aggregate gross proceeds of $915,000.

Each Unit consists of one (1) common share of the Company ("Share") and one (1) common share purchase warrant ("Warrant"). Each Warrant will entitle the holder thereof to acquire one Share of the Company at a price of $0.05 per Share for a period of eighteen (18) months from the date of issuance.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Reports Positive Cash Flow in Q3

ScreenPro Reports Positive Cash Flow in Q3

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") announces its financial results for the third quarter. The Company has filed its financial statements ("FS") and related management discussion and analysis ("MD&A") on SEDAR for the quarterly results ending September 30, 2022 ("Q3 2022").

Q3 2022 Financial Summary

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Announces Non-Brokered Private Placement Financing

ScreenPro Announces Non-Brokered Private Placement Financing

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce a non-brokered private placement financing of up to 20 million units of the Company ("Units") at a price of $0.05 per Unit (the "Private Placement").

Each Unit will consist of one (1) common share of the Company ("Share") and one (1) common share purchase warrant ("Warrant"). Each warrant will entitle the holder thereof to acquire one Share of the Company at a price of $0.05 per Share for a period of eighteen (18) months from the date of issuance.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ScreenPro Reports a Major Increase in Positive Test Results

ScreenPro Reports a Major Increase in Positive Test Results

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") would like to share an internal report indicating the Company's Covid PCR (Polymerase Chain Reaction) testing has experienced a significant spike in positivity rates in their testing results in the film and production industry.

According to our PCR testing data, the positivity rate is significantly higher today at the same time last year. Below you will find our year-over-year findings:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Juniper Networks Announces Date of First Quarter Preliminary Financial Results Conference Call

Juniper Networks Announces Date of First Quarter Preliminary Financial Results Conference Call

Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced it will release preliminary financial results for the quarter ended March 31, 2023 on Tuesday, April 25, 2023 after the close of the market. The Company's senior management will host a conference call that day at 2:00 pm PT.

Commentary by Ken Miller, chief financial officer, reviewing the Company's first quarter financial results, as well as the second quarter 2023 financial outlook, will be published on the Company's website at http://investor.juniper.net . Analysts and investors are encouraged to review this commentary prior to participating in the conference call.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Marvel Commences Final Study Required Prior to Initiating Human Trials

Marvel Commences Final Study Required Prior to Initiating Human Trials

Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that it has initiated the 4-week good laboratory practice (GLP) FDA investigational new drug (IND) enabling dose-ranging dog studies for its lead drug candidate MB-204.

"This dog study is the last of the two key primary animal studies we need to complete before entering phase 1 human clinical testing of our lead asset - MB-204," said Dr. Mark Williams, Chief Science Officer of Marvel Biosciences. "We are now planning our Phase 1 human trials, likely to be conducted in Australia upon the successful conclusion of this study and the previously commenced 4-week rat GLP study."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Enterprise Group Announces Results for Fourth Quarter and Full Year 2022

Enterprise Group Announces Results for Fourth Quarter and Full Year 2022

Enterprise Group, Inc. (TSX: E) (OTCQB: ETOLF) (the "Company" or "Enterprise"). Enterprise, a consolidator of energy services (including specialized equipment rental to the energyresource sector), is pleased to announce its Q4 2022 and FY2022 results.

OVERALL PERFORMANCE AND RESULTS OF OPERATIONS

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Montfort Capital Reports Strong Preliminary Unaudited Results Within Consumer Lending Segment for FY2022

Montfort Capital Reports Strong Preliminary Unaudited Results Within Consumer Lending Segment for FY2022

Montfort Capital Corp. ("Montfort" or the "Company") (TSXV: MONT) (OTCQB: MONTF) a leading alternative lender utilizing focused strategies, experienced management teams and advanced technology, is pleased to report selected preliminary unaudited results related to its consumer lending segment, which alone has established a significant investment base of over $365 million in Assets Under Management and Administration ("AUMA") as at December 31, 2022 . For comparison, as at December 31, 2021 the Company had $nil AUMA in its consumer lending segment and $125 million in Total Assets. This consumer lending business' growth was driven exponentially through the acquisitions of Brightpath Capital Corporation ("Brightpath") in August 2022 and 78% of Langhaus Financial Partners Inc. ("Langhaus") in October 2022 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Montfort Capital Announces Quarterly Cash Dividend on Series A Class A Preferred Shares

Montfort Capital Announces Quarterly Cash Dividend on Series A Class A Preferred Shares

Monfort to pay cash dividend payment to Series A Class A Preferred Shareholders of record on March 24th

Montfort Capital Corp. ("Montfort" or the "Company") (TSXV: MONT) (OTCQB: MONTF), a leading alternative lender utilizing focused strategies, experienced management teams and advanced technology, today announced that the Company's board of directors has declared a quarterly cash dividend (the "Quarterly Dividend") of $0.02 per Series A Class A Preferred Shares (each, a "Preferred Shares"), payable on March 31, 2023 to holders of Preferred Shares of record as  at March 24, 2023 . The Quarterly Dividend qualifies as an 'eligible dividend' for Canadian income tax purposes.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Marvell Technology, Inc. Declares Quarterly Dividend Payment

Marvell Technology, Inc. Declares Quarterly Dividend Payment

Marvell Technology, Inc. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on April 26, 2023 to shareholders of record as of April 7, 2023 .

About Marvell

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×